PMI Innovation Conference in Abu Dhabi: Promoting Smoke-Free Future

PMI by 2FIRSTS.ai
Dec.23.2024
PMI Innovation Conference in Abu Dhabi: Promoting Smoke-Free Future
Philip Morris International (PMI) held a technology innovation conference in Abu Dhabi, showcasing new tobacco products and health benefits.

According to a report by Kaktus.Media on December 23rd, Philip Morris International (PMI) recently held a technology innovation international conference in Abu Dhabi, United Arab Emirates.


During the meeting, PMI provided a detailed overview of its development history, focusing on the turning point in 2014 when it launched its first heated tobacco device. The company executives showcased data on smoking cessation and adoption of new tobacco products in various regions across the globe, with particular emphasis on the outstanding performance in countries such as Sweden, Switzerland, and Japan.


President of Philip Morris International (PMI) for South Asia, Southeast Asia, the CIS, the Middle East, and North Africa, Fred de Wilde, revealed the commercial benefits of PMI's promotion of the concept "If you don't smoke, don't start; if you smoke, quit; if you don't quit, change" in an interview with Kaktus.Media. He emphasized that the promotion of new tobacco products is not only beneficial for the company but also helps to improve public health levels.


PMI presented a two-year study at the conference, which covered 37 healthcare facilities from Europe and Asia, with a total of 900 participants. The results showed that individuals using new tobacco products experienced similar health improvements as those who quit smoking, while the health of those who continued smoking deteriorated significantly.


When discussing legislation in Central Asia, the official pointed out that the regulation of e-cigarettes in the region is aimed at preventing minors from accessing the products. However, he also mentioned that if suitable alternatives are not provided for adult smokers, it could lead to an increase in cigarette consumption. In response, PMI emphasized that their products are only sold to registered and confirmed adult smokers to ensure strict control over the sales process.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BAT Confirms Vuse Marketing Success in H2, Federal Crackdown Key Driver
BAT Confirms Vuse Marketing Success in H2, Federal Crackdown Key Driver
BAT confirms significant improvement in Vuse's performance, attributing it to federal crackdown on illegal competitors, creating a unique market opportunity.
Dec.09 by 2FIRSTS.ai
Altria Q3 2025 Earnings Report: Net Revenue of $6.072 Billion and Launch of on!PLUS in the U.S.
Altria Q3 2025 Earnings Report: Net Revenue of $6.072 Billion and Launch of on!PLUS in the U.S.
Altria reported Q3 2025 net revenue of $6.072 billion, a 3.0% year-on-year decline. Adjusted EPS increased 3.6% to $1.45. The company expanded its share repurchase program to $2 billion and launched the on!PLUS nicotine pouch in Florida, North Carolina, and Texas.
Oct.31 by 2FIRSTS.ai
ZYN Nicotine Pouches Seek MRTP Authorization; FDA Sets January Meeting
ZYN Nicotine Pouches Seek MRTP Authorization; FDA Sets January Meeting
The U.S. FDA has scheduled a Tobacco Products Scientific Advisory Committee (TPSAC) meeting for January 22, 2026, to review Swedish Match USA’s Modified Risk Tobacco Product (MRTP) applications for 20 ZYN nicotine pouch products. Although the products gained PMTA authorization in early 2025, MRTP approval is required for marketing them with reduced-risk claims.
Nov.24 by 2FIRSTS.ai
Bangladesh Tobacco Control Group Urges Reversal of Philip Morris Nicotine Pouch Factory Approval
Bangladesh Tobacco Control Group Urges Reversal of Philip Morris Nicotine Pouch Factory Approval
Advocates say the economic authority’s decision contradicts national health goals and violates a Supreme Court directive banning new tobacco ventures.
Oct.27 by 2FIRSTS.ai
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai
62.5% of Vapers Still Use Disposables; 82% for Ages 25–34, Survey Finds
62.5% of Vapers Still Use Disposables; 82% for Ages 25–34, Survey Finds
Vape retailer Haypp reports that 62.5% of vapers still use disposable vapes, rising to 82% among those aged 25–34. 35% of disposable users say they are still buying disposables. Black-market purchases reportedly come mainly from local smaller shops (55%) and specialist vape stores (37%), as well as supermarkets, online retailers and car boot sales. 78.5% of respondents are using pre-ban stock, posing safety risks from aging lithium-ion batteries; 14% plan to continue buying disposables,.
Oct.23 by 2FIRSTS.ai